Search Keyword:


Search option:


IID00227
UniprotQ9UQF2
ProteinC-Jun-amino-terminal kinase-interacting protein 1
GeneMAPK8IP1
OrganismHomo sapiens
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
Network xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
711
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 157-167 Hetero dimer : IID00270Complex
 Evidence X-RAY 2g01 F Reference
       Region 2g01 F 157-157 disorder
       Region 2g01 F 158-166 order
       Region 2g01 F 167-167 disorder
 Evidence X-RAY 2g01 G Reference
       Region 2g01 G 157-157 disorder
       Region 2g01 G 158-166 order
       Region 2g01 G 167-167 disorder
 Evidence X-RAY 2gmx F Reference
       Region 2gmx F 157-157 disorder
       Region 2gmx F 158-167 order
 Evidence X-RAY 2gmx G Reference
       Region 2gmx G 157-157 disorder
       Region 2gmx G 158-166 order
       Region 2gmx G 167-167 disorder
 Evidence X-RAY 2h96 F Reference
       Region 2h96 F 157-157 disorder
       Region 2h96 F 158-167 order
 Evidence X-RAY 2h96 G Reference
       Region 2h96 G 157-157 disorder
       Region 2h96 G 158-167 order
 Evidence X-RAY 3vud F Reference
       Region 3vud F 157-157 disorder
       Region 3vud F 158-167 order
 Evidence X-RAY 3vug F Reference
       Region 3vug F 157-157 disorder
       Region 3vug F 158-167 order
 Evidence X-RAY 3vuh F Reference
       Region 3vuh F 157-157 disorder
       Region 3vuh F 158-167 order
 Evidence X-RAY 3vui F Reference
       Region 3vui F 157-157 disorder
       Region 3vui F 158-167 order
 Evidence X-RAY 3vuk F Reference
       Region 3vuk F 157-157 disorder
       Region 3vuk F 158-167 order
 Evidence X-RAY 3vul F Reference
       Region 3vul F 157-157 disorder
       Region 3vul F 158-167 order
 Evidence X-RAY 3vum F Reference
       Region 3vum F 157-167 order
 Evidence X-RAY 4e73 B Reference
       Region 4e73 B 158-166 order
       Region 4e73 B 167-167 disorder
 Evidence X-RAY 4g1w B Reference
       Region 4g1w B 157-157 disorder
       Region 4g1w B 158-166 order
       Region 4g1w B 167-167 disorder
 Evidence X-RAY 4hys B Reference
       Region 4hys B 157-157 disorder
       Region 4hys B 158-166 order
       Region 4hys B 167-167 disorder
 Evidence X-RAY 4hyu B Reference
       Region 4hyu B 157-157 disorder
       Region 4hyu B 158-166 order
       Region 4hyu B 167-167 disorder
 Evidence X-RAY 4izy B Reference
       Region 4izy B 157-157 disorder
       Region 4izy B 158-166 order
       Region 4izy B 167-167 disorder
Seq 157-167 Hetero dimer : IID00456Complex
 Evidence X-RAY 3oxi J Reference
       Region 3oxi J 158-167 order
 Evidence X-RAY 3ptg J Reference
       Region 3ptg J 157-157 disorder
       Region 3ptg J 158-167 order
 Evidence X-RAY 4h39 B Reference
       Region 4h39 B 158-167 order
Seq 157-167 Hetero trimer : IID00270Complex
 Evidence X-RAY 5lw1 C Reference
       Region 5lw1 C 157-157 disorder
       Region 5lw1 C 158-166 order
       Region 5lw1 C 167-167 disorder
Seq 157-167 Hetero trimer : IID00270Complex
 Evidence X-RAY 5lw1 F Reference
       Region 5lw1 F 157-157 disorder
       Region 5lw1 F 158-166 order
       Region 5lw1 F 167-167 disorder
Seq 157-167 Hetero trimer : IID00270Complex
 Evidence X-RAY 5lw1 I Reference
       Region 5lw1 I 157-157 disorder
       Region 5lw1 I 158-167 order
Seqphosphorylation
    369-369 Phosphoserine
    407-407 Phosphoserine
    409-409 Phosphoserine
    411-411 Phosphothreonine
    444-444 Phosphoserine
    447-447 Phosphoserine
    448-448 Phosphothreonine
    469-469 Phosphoserine
    471-471 Phosphoserine
    472-472 Phosphoserine
    473-473 Phosphoserine
    195-195 Phosphoserine
    15-15 Phosphoserine
    29-29 Phosphoserine
    40-40 Phosphoserine
    103-103 Phosphothreonine; by MAPK8
    152-152 Phosphoserine
    181-181 Phosphoserine
    187-187 Phosphoserine
    193-193 Phosphoserine
    366-366 Phosphoserine
    196-196 Phosphoserine
    205-205 Phosphothreonine; by MAPK8
    214-214 Phosphoserine
    311-311 Phosphoserine
    328-328 Phosphoserine
    330-330 Phosphoserine
    340-340 Phosphoserine
    355-355 Phosphoserine
 
Prediction
NeProc
Disorder 1-69,74-491
Order 70-73,492-602,608-711
ProS 22-69,74-77,84-90,160-191,262-271,280-286,294-315,324-337,370-404,410-418,423-429,458-469,482-486
AlphaFold
Disorder 1-482,486-488,548-562,623-636,664-665,697-711
Order 483-485,489-547,563-622,637-663,666-696
Pfam Hmmer
PF00018 491-547 8e-05
PF00640 567-701 1.2e-50
SEG 6-25 ,39-52 ,72-87 ,104-127 ,139-153 ,246-258 ,466-481 ,504-519
Function
Function in SwissProt
The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module. Required for JNK activation in response to excitotoxic stress. Cytoplasmic MAPK8IP1 causes inhibition of JNK-regulated activity by retaining JNK in the cytoplasm and inhibiting JNK phosphorylation of c-Jun. May also participate in ApoER2-specific reelin signaling. Directly, or indirectly, regulates GLUT2 gene expression and beta-cell function. Appears to have a role in cell signaling in mature and developing nerve terminals. May function as a regulator of vesicle transport, through interactions with the JNK-signaling components and motor proteins. Functions as an anti-apoptotic protein and whose level seems to influence the beta-cell death or survival response. Acts as a scaffold protein that coordinates with SH3RF1 in organizing different components of the JNK pathway, including RAC1 or RAC2, MAP3K11/MLK3 or MAP3K7/TAK1, MAP2K7/MKK7, MAPK8/JNK1 and/or MAPK9/JNK2 into a functional multiprotein complex to ensure the effective activation of the JNK signaling pathway. Regulates the activation of MAPK8/JNK1 and differentiation of CD8(+) T-cells.